Results 101 to 110 of about 3,487 (207)

What's new in NMOSD and MOGAD?

Revue Neurologique
In this mini-review, we focus on novelties in the field of neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD). We first describe the proposed criteria for MOGAD and evaluate their impact and potential limitations, with a highlight on the subgroups of patients tested MOG-antibody ...
openaire   +2 more sources

Serum homocysteine levels predict poor recovery and relapse in first-attack myelin oligodendrocyte glycoprotein antibody disease

Frontiers in Neurology
Background and objectiveMyelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an inflammatory demyelinating disease with a high risk of recurrence and progressive disability, and it is crucial to find sensitive and reliable biomarkers for ...
Yanfei Li, Yanjie Jia
doaj   +1 more source

Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series

Frontiers in Immunology
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) caused by pathogenic immunoglobulin G antibodies to myelin oligodendrocyte glycoprotein is a rare demyelinating disease of the central nerve system (CNS).
Chen Min, Bi Zhuajin, Liu Peidong, Li Ruoyu, Liu Ju, Liu Hongbo   +5 more
doaj   +1 more source

Uncommon alliance between MOGAD and Behçet's disease

Oxford Medical Case Reports
Abstract Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a newly recognized demyelinating disease with diverse clinical and radiological manifestations that continue to expand over time. Its coexistence with Behçet's disease, a multisystem inflammatory disorder, has not been previously reported.
Asmae Sikkal, Maha Abdallaoui, Salma Bellakhdar, Hajar Khattab, Kamal Haddouali, E L Moutawakil Bouchra, Mohammed Abdoh Rafai, E L Otmani Hicham   +7 more
openaire   +3 more sources

Neuropsychological outcomes in paediatric MOGAD: clinical practice and future research.

MOG-ab associated disorders (MOGAD) are a recently characterised demyelinating condition that affects children and adults. Due to its recent discovery, the effect that MOGAD has on children’s cognitive abilities is only just being understood.
Sarah Rudebeck
core   +1 more source

Frequency of Increased Intracranial Pressure in MOGAD

There are a few case reports of bilateral optic disc edema and raised opening pressure (OP) on lumbar puncture (LP) in myelin-oligodendrocyte-glycoprotein-antibody-associated-disease (MOGAD), which could cause diagnostic confusion between MOGAD with ...
Nanthaya Tisavipat; Natthapon Rattanathamsakul; Abdul-Rahman Salman; Vyanka Redenbaugh; Laura Cacciaguerra; Deena Tajfirouz; Kevin Chodnicki; Jan-Mendelt Tillema; Sean Pittock; Eoin Flanagan; John Chen
core  

Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Qualitative Patient and Clinician Interviews Informing the Development of a Conceptual Model

Neurology and Therapy
Introduction Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare, autoimmune demyelinating central nervous system disease.
Jeffrey L. Bennett, Asha Paireddy, Charlotte Cox, Megan Mayhew, Julia Stein, Teresa Gasalla, Béatrice Tugaut   +6 more
doaj   +1 more source

Myelin oligodendrocyte glycoprotein antibody-associated disease mimicking CLIPPERS syndrome: case report and literature review

Heliyon
Introduction: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a central nervous system's autoimmune disorder caused by antibodies targeting the oligodendrocyte glycoprotein.
Julio César Mantilla - Pardo, Jose Ricardo Muñoz - Zuñiga, Juan David Tascón - Romero, Jairo Alonso Quiñones - Bautista   +3 more
doaj   +1 more source

Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)

BMJ Neurology Open
Background Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated diseases (MOGAD) impose psychological burdens on patients.
, Judith Bellmann-Strobl, Philipp Albrecht, Klemens Ruprecht, Friedemann Paul, Clemens Warnke, Natalia Kurka, Frederike Cosima Oertel, Susanna Asseyer, Sergiu Groppa, Klaus-Peter Wandinger, Heinz Wiendl, Volker Kunzmann, Ralf Gold, Matthias Schwab, Kevin Rostásy, Orhan Aktas, Klemens Angstwurm, Antonios Bayas, Achim Berthele, Benedikt Frank, Kerstin Hellwig, Olaf Hoffmann, Sven Meuth, Sebastian Rauer, Ulf Ziemann, Tania Kümpfel, Uwe Zettl, Stefan Bittner, Bernhard Hemmer, Maria Seipelt, Marius Ringelstein, Carsten Finke, Maria Hastermann, Steffen Pfeuffer, Refik Pul, Marc Pawlitzki, Christoph Kleinschnitz, Christoph Mayer, Claudia Sommer, Alexander Winkelmann, Frauke Zipp, Arne Riedlinger, Mathias Buttmann, Thorleif Etgen, Stefanie Behnke, Florian Then Bergh, Achim Gass, Wolfgang Kohler, Markus Krumbholz, Anna Gahlen, Florence Pache, Christian Geis, Martin Marziniak, Oliver Neuhaus, Corinna Trebst, Arthur Melms, Peter Lüdemann, Frank Leypoldt, Ralf Linker, Paulus Rommer, Yasemin Goereci, Marina Herwerth, Michelle Maiworm, Vivien Häußler, Daniel Engels, Julian Reza Kretschmer, Ilya Ayzenberg, Carolin Schwake, Patrick Schindler, Martin W Hümmert, Natalie Bednarz, Franziska Bütow, Eva Dawin, Ankelien Duchow, Katinka Fischer, Moritz Förster, Mathias Fousse, Frank Freitag, Johannes Gehrig, Katrin Giglhuber, Ana Beatriz Ayrosa Galvao Ribeiro Gomes, Jonas Graf, Julia Gutbrod, Kerstin Guthke, Axel Haarmann, Mariella Herfurth, Frank Hoffmann, Ulrich Hofstadt-van Oy, Leila Husseini, Kathleen Ingenhoven, Jutta Junghans, Matthias Kaste, Karsten Kern, Peter Kern, Pawel Kermer, Kimberly Körbel, Markus Kowarik, Markus Krämer, Theodoros Ladopoulos, Andrea Landwehr, Stefan Langel, Ann Sophie Lauenstein, Sarah Laurent, De-Hyung Lee, Dominik Lehrieder, Martin Liebetrau, Gero Lindenblatt, Lisa Lohmann, Stefanie Meister, Mathias von Mering, Imke Metz, Jasmin Naumann, Marjan Nenkov, Tradite Neziraj, Moritz Niederschweiberer, Sabine Niehaus, Carolin Otto, Thivya Pakeerathan, Sandra Paryjas, Sulyn Pepping, Mosche Pompsch, Roxanne Alice Pretzsch, Anne-Katrin Proebstel, Maria Protopapa, Hans-Ulrich Puhlmann, Torsten Rehfeldt, Nele Retzlaff, Veith Rothhammer, Lioba Rückriem, Christoph Ruschil, Carina Saggau, Muriel Schraad, Patricia Schwarz, Jörn Peter Sieb, Gilberto Soloroza, Alexander Stefanou, Andrea Steinbrecher, Heike Stephanik, Verena Steuerwald, Muriel Stoppe, Klarissa Stürner, Marie Süße, Athanasios Tarampanis, Simone Tauber, Daria Tkachenko, Thanos Tsaktanis, Hayrrettin Tumani, Ulrike Wallwitz, Anna Walz, Martin S. Weber, Jens Weise, Jonathan Wickel, Felix Wohlrab, Yavor Yalachkov, Clarissa Zappe, Felix Lüssi, Tanja Zimmermann   +157 more
doaj   +1 more source

Multi-tracer PET and MR imaging visualize distinct metabolic and inflammatory profiles in the white matter of NMOSD and MOGAD

Neurotherapeutics
This study investigates distinct neuroinflammatory patterns in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) using multi-tracer PET and MR imaging. Eight NMOSD (5F/3M; median age 36.5) and
Shuwei Bai, Hongda Shao, Hong Yang, Kan Wang, Chenpeng Zhang, Qiuju Li, Jie Ding, Chong Xie, Tao Xue, Yong Hao, Jianjun Liu, Yangtai Guan   +11 more
doaj   +1 more source